Sanofi

ISIN FR0000120578 Symbol SAN Industry Drug Manufacturers-General Sector Healthcare
Sanofi Price
86.75EUR 0.15%
1y Low: 74.9
1y High: 95.8
1y Low: 74.9
1y High: 95.8
sanofi.com
Market Cap
126.7 B USD
Dividend Yield
3.7%
Performance 1y
1.01 %
PER
8.9

Sanofi Stock Chart

Sanofi Dividend Chart

Sanofi Dividend Calendar

Year # Div. Div. Paid Div. Yield Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021 1 3.20 EUR 3.7 %
2020 1 3.15 EUR 4.0 %
2019 1 3.07 EUR 3.5 %
2018 1 3.03 EUR 4.3 %
2017 1 2.96 EUR 4.5 %
2016 1 2.93 EUR 4.6 %
2015 1 2.85 EUR 4.4 %
2014 1 2.80 EUR 4.6 %
2013 1 2.77 EUR 4.7 %
2012 1 2.65 EUR 5.0 %
2011 2 5.00 EUR 13.2 %
2010 1 2.40 EUR 7.3 %
2009 2 4.40 EUR 12.2 %
2008 2 4.14 EUR 15.1 %
2007 2 3.50 EUR 9.5 %
2006 2 3.04 EUR 7.6 %
2005 2 1.48 EUR 3.6 %
2004 2 1.02 EUR 3.2 %
2003 1 0.84 EUR 2.6 %
2002 1 0.66 EUR 2.2 %
2001 1 0.44 EUR 1.0 %
2000 1 0.32 EUR 1.0 %
1999 1 0.28 EUR 1.4 %
1998 1 0.27 EUR 1.5 %
1997 1 0.25 EUR 2.0 %
1996 1 0.24 EUR 2.4 %
1995 1 0.21 EUR 3.6 %
1994 1 0.21 EUR 4.9 %
1993 1 0.21 EUR 5.0 %
1992 1 0.20 EUR 4.5 %
1991 1 0.19 EUR 4.7 %
1990 1 0.18 EUR 4.6 %

Sanofi Performance

1 Week
1 Month
6 Months
4.82 %
Year to Date
9.81 %
1 Year
1.01 %
5 Years
45.29 %

Sanofi Revenue, EBIT, and Income

Sanofi Margins

Sanofi Shares Outstanding

Useful Links

Search Twitter: $SAN, #SAN

Sanofi Company Info

Sanofi provides therapeutic solutions worldwide. It offers Cerezyme and Cerdelga for Gaucher, Myozyme and Lumizyme for Pompe, Fabrazyme for Fabry, and Aldurazyme for mucopolysaccharidosis Type 1; and Aubagio and Lemtrada for multiple sclerosis. It also provides Dupixent for atopic dermatitis; Kevzara for rheumatoid arthritis; Eloctate and Alprolix to treat hemophilia; and Cablivi to treat acquired thrombotic thrombocytopenic purpura. In addition, it offers Libtayo for metastatic cutaneous squamous cell carcinoma; Jevtana and Taxotere taxane for cancers; Eloxatin for colon cancer; Thymoglobulin, an immunosuppressive and immunomodulating agent; Mozobil for hematologic malignancies; and Zaltrap for metastatic colorectal cancer. Further, it provides Lantus, Toujeo, Apidra, and Insuman insulins; Amaryl sulfonylurea; Adlyxin/Lyxumia, a GLP-1 receptor agonist; Soliqua 100/33/Suliqua, an insulin glargine and lixisenatide combination to treat diabetes; Admelog/Insulin lispro insulin; Praluent, a cholesterol-lowering drug; and Multaq, an anti-arrhythmic drug. Additionally, it offers Plavix for atherothrombotic conditions; Lovenox for the prophylaxis, venous thromboembolism, and acute coronary syndrome; Aprovel and CoAprovel anti-hypertensives; Renagel and Renvela for patients undergoing dialysis; Synvisc and Synvisc-One viscosupplements for osteoarthritis; Stilnox for insomnia; Allegra for seasonal allergic rhinitis and uncomplicated hives; and Depakine for epilepsy. It also provides generic products; and products for allergy, cough, cold, pain, nutrition, digestion, pediatrics, influenza, meningitis, travel, and endemic vaccines; and adult and adolescent boosters. Sanofi has collaborations with Verily Life Sciences LLC; Happify Health; GlaxoSmithKline Plc; Kymera Therapeutics; Parkinson's Foundation, Inc.; and Nurix Therapeutics, Inc. The company was formerly known as Sanofi-Aventis. Sanofi was incorporated in 1994 and is headquartered in Paris, France.

Sanofi Price to Earnings Ratio (PE Ratio): 8.9

The current Price to Earnings Ratio of Sanofi is 8.9.
The PE Ratio is calcluated by dividing the current Sanofi share price (86.75 EUR) by the earnings per share (9.8).

Sanofi Dividend Yield: 3.7%

The current Dividend Yield of Sanofi is 3.7%.

Sanofi Market Cap: 126.7 B USD

The current market cap of Sanofi is 126.7 B USD.

Sanofi Stock Price: 86.75 EUR

The current stock price of Sanofi is 86.75 EUR (101.7 USD).

Sanofi ISIN: FR0000120578

The ISIN (International Securities Identification Number) of Sanofi is FR0000120578.

Sanofi Ticker Symbol: SAN

The ticker symbol of Sanofi is SAN.

Sanofi Address

The address of the Sanofi HQ is 54, Rue La BoEtie, 75008 Paris, France.